Results 31 to 40 of about 2,056 (184)

Skin barrier function defect - A marker of recalcitrant tinea infections

Indian Dermatology Online Journal, 2020
Context: Recently, there has been an increase in the number of chronic, recurrent, and recalcitrant dermatophytosis. Many factors implicated are barrier defects, aberrant host immune response, application of steroids or other irrational combination ...
Puneet Bhargava, Shivi Nijhawan, Heena Singdia, Taniya Mehta   +3 more
doaj   +1 more source

Efficacy of 1% terbinafine and 1% luliconazole in the management of tinea corporis and tinea cruris

National Journal of Physiology, Pharmacy and Pharmacology, 2020
Background: Tinea or dermatophytosis is a fungal infection that commonly affects stratum corneum of the skin and its other appendages. Topical antifungal agents are the first-line treatment choice for dermatophytosis among them terbinafine, luliconazole,
Aditya Jillella, Sameer Uz Zaman, Venkateshwarlu Yeldandi, Naga Teja Pavani A   +3 more
doaj   +1 more source

Mycosis Fungoides Mimicking Tinea Cruris: A Case Report Tinea Krurisi Taklit Eden Mikozis Fungoides: Olgu Sunumu

, 2023
Mycosis fungoides is the most common primary cutaneous T cell lymphoma. Mycosis fungoides can mimic various skin diseases due to its different clinical types and rare clinical presentations.
Gharehdaghi, Sheyda, ŞİMŞEK, BERKAY, TANRIBİLİR, MAHMUT ESAT, ERDEM, ÖZLEM, TAMER, FUNDA   +4 more
core   +1 more source

Evaluating diagnostic utility of PAS stained skin scrape cytology smear in clinically suspected superficial cutaneous mycoses: A simple yet unpracticed technique

Journal of Family Medicine and Primary Care, 2022
Background and Objectives: For fungal dermatitis, a wet Potassium Hydroxide (KOH) preparation of the skin scrapings forms the routine practice for diagnosis.
Ujjawal Khurana, Annika Marwah, Vivek Dey, Upasana Uniya, Rakesh Hazari   +4 more
doaj   +1 more source

Efficacy and safety of different terbinafine regimens in patients of recurrent tinea corporis and cruris

, 2021
Background: Tinea corporis and cruris is said to be recurrent when there is relapse of sign and symptoms after 6 weeks of cure. Recently, there has been increase in cases of recurrent tinea corporis and cruris, with atypical lesions.
Verma, Noopur, Dayal, Surbhi, Gupta, M. C., Verma, Savita   +3 more
core   +1 more source

MiR-155, a potential serum marker of extramammary Paget’s disease

BMC Cancer, 2018
Background Extramammary Paget’s disease (EMPD), a rare skin malignancy with non-specific manifestations, is often misdiagnosed as eczema of scrotum or tinea cruris.
Hao Guo, Rui-Qun Qi, Jie Sheng, Chang Liu, Hang Ma, He-Xiao Wang, Jiu-Hong Li, Xing-Hua Gao, Yin-Sheng Wan, Hong-Duo Chen   +9 more
doaj   +1 more source

Comparison Of Therapeutic Effectiveness With Clotrimazole 1% Cream With Terbinafine 1% Cream In Patients Therapy Given To Tinea Corporis And Tinea Cruris In Kashan

پیاورد سلامت, 2015
Background and Aim: Dermatophytosis is a skin infection without involving of hair, and in fact, Tinea cruris is a form of body Dermatophytosis. For treatment of these two diseases, topical azole or Alylamines are usually used.
Rezvan Talaee, Mohammad Dakhili, Mohammad Ali Asadi, Seyed Hamed Sharif Arani, Hossein Akbari, Afshin Salehi   +5 more
doaj   +2 more sources

Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Dermatophyte infections of the dermis and subcutaneous tissue (i.e. deep dermatophytosis)—associated with secondary complications including pseudomycetoma and systemic dissemination—affect vulnerable populations with primary or acquired immunodeficiencies.
Aditya K. Gupta, Tong Wang, Susmita, Ditte Marie L. Saunte, Roderick Hay, Vincent Piguet   +5 more
wiley   +1 more source

Chronic eczema developing over skin treated for dermatophytosis in atopic patients -Importance of treating gently and intelligently

Indian Journal of Dermatology, 2022
A novel observation of chronic eczema developing over the skin of adequately treated lesions of tinea cruris/tinea corporis in six atopic individuals is being shared.
Shyam Verma, Ramkumar Ramamoorthy, J Vasani Resham   +2 more
doaj   +1 more source

Itraconazole in the treatment of tinea corporis and tinea cruris

Clinical and Experimental Dermatology, 1993
Forty-five patients with tinea corporis or tinea cruris were treated with oral itraconazole 100 mg daily for 15 days. At the end of the 15-day treatment, 80% of the patients were healed or had markedly improved. At the first follow-up visit, 2 weeks after stopping therapy, 80% of patients were considered responders.
KATSAMBAS, A, ANTONIOU, C, FRANGOULI, E, RIGOPOULOS, D, VLACHOU, M, MICHAILIDIS, D, STRATIGOS, J   +6 more
openaire   +3 more sources